Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatology Other
    Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Canakinumab Gives Faster, Greater Pain Relief in Refractory Gout Patients: Presented at ACR/ARHP - (DGDispatch)
    Previous Urate-Lowering Therapy Plus Febuxostat Lowers Urate Levels, Number of Flares in Patients With Gout: Presented at ACR/ARHP - (DGDispatch)
    Low-Dose Colchicine Eases Pain Due to Acute Gout Flare: Presented at ACR/ARHP - (DGDispatch)
    Combination Therapy With Zoledronic Acid/Teriparatide Has Beneficial Effects on Bone Mass Density: Presented at ACR/ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatology Other
    Biologics and Infections: Common and Rare

    Webcasts/CME archive

     Recent cases - Rheumatology Other
      Rectal Mucosal Prolapse Syndrome as an Unusual Gastrointestinal Manifestation of Sjogren's Syndrome: A Case Report
      HELLP Syndrome, Multiple Liver Infarctions, and Intrauterine Fetal Death in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
      Nasal Septal Perforation in a Patient with Takayasu's Arteritis; a Rare Association
      Nummular Keratopathy in a Patient with Hyper-IgD Syndrome
      Congenital Heart Block Associated with Sjogren Syndrome: Case Report

      Cases archive
        




      my personal edition > rheumatology other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Gout Associated With Subsequent Cardiac Arrhythmia

      A DGReview of :"Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia"
      Journal of Rheumatology

      06/22/2004
      By Emma Hitt, PhD


      Gout appears to be associated with the occurrence of subsequent cardiac arrhythmia, a new study suggests. In addition, hypertension appears to be the major risk factor that aggravates development of atherosclerosis in hyperuricaemic patients.

      Concentrations of serum uric acid, the end-product of purine metabolism, are often elevated in patients with hypertension or ischaemic heart disease. However, the role of uric acid and gout in the development of cardiovascular diseases is unclear.

      Juan-Chia Lin, MD, with the National Yang-Ming University, in Taipei, Taiwan, and colleagues conducted a 7-year follow-up study among 391 men with hyperuricaemia. Participants were all at least 30 years of age and screened from a community-based study that initially took place in 1991-92. Of the participants in that study, 75% were later assessed again in 1997-98.

      Factors for coronary heart disease included age, increase of uric acid level, baseline systolic blood pressure, and increase of systolic blood pressure while factors associated with left ventricular hypertrophy included baseline systolic blood pressure and increase in systolic blood pressure, the researchers report.

      They also found that gouty syndrome, age, baseline fasting plasma glucose level, and increase of systolic blood pressure were significantly related to cardiac arrhythmia.

      In addition, after adjustment for baseline serum uric acid level, hyperuricaemic men with hypertension, especially overt hypertension stage 2 and stage 3, was related to cardiovascular disease incidence, and this association was synergistic with uric acid level.

      While gout and elevated uric acid level seemed not to be an independent risk factor for most cardiovascular diseases, blood pressure level was predictive for cardiovascular disease incidence synergistically with serum uric acid level, Dr. Lin and colleagues conclude.

      "Although hyperuricemia and hypertension are clearly linked, the mechanisms underlying this relation are uncertain," the authors note.

      Hyperuricaemia may predispose patients to the development of hypertension, or it may influence the rate of blood pressure progression and/or its effects on other organs such as the kidney, heart brain, or vascular endothelium, they suggest.



      J Rheumatol 2004;31:1152-1158. "Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send